vs

Side-by-side financial comparison of NL INDUSTRIES INC (NL) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $37.7M, roughly 1.2× NL INDUSTRIES INC). NL INDUSTRIES INC runs the higher net margin — -82.2% vs -90.4%, a 8.3% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -1.9%). NL INDUSTRIES INC produced more free cash flow last quarter ($-4.7M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -0.4%).

NL Industries, formerly known as the National Lead Company, is a lead smelting company currently based in Houston, Texas. National Lead was one of the 12 original stocks included in the Dow Jones Industrial Average at the time of its creation on May 26, 1896.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

NL vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.2× larger
PACB
$44.6M
$37.7M
NL
Growing faster (revenue YoY)
PACB
PACB
+15.7% gap
PACB
13.8%
-1.9%
NL
Higher net margin
NL
NL
8.3% more per $
NL
-82.2%
-90.4%
PACB
More free cash flow
NL
NL
$15.2M more FCF
NL
$-4.7M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-0.4%
NL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NL
NL
PACB
PACB
Revenue
$37.7M
$44.6M
Net Profit
$-31.0M
$-40.4M
Gross Margin
32.1%
37.1%
Operating Margin
7.6%
-92.3%
Net Margin
-82.2%
-90.4%
Revenue YoY
-1.9%
13.8%
Net Profit YoY
-287.2%
-1802.7%
EPS (diluted)
$-0.63
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NL
NL
PACB
PACB
Q4 25
$37.7M
$44.6M
Q3 25
$40.0M
$38.4M
Q2 25
$40.4M
$39.8M
Q1 25
$40.3M
$37.2M
Q4 24
$38.4M
$39.2M
Q3 24
$33.7M
$40.0M
Q2 24
$35.9M
$36.0M
Q1 24
$38.0M
$38.8M
Net Profit
NL
NL
PACB
PACB
Q4 25
$-31.0M
$-40.4M
Q3 25
$-7.9M
$-38.0M
Q2 25
$355.0K
$-41.9M
Q1 25
$667.0K
$-426.1M
Q4 24
$16.5M
$2.4M
Q3 24
$36.0M
$-60.7M
Q2 24
$7.8M
$-173.3M
Q1 24
$6.8M
$-78.2M
Gross Margin
NL
NL
PACB
PACB
Q4 25
32.1%
37.1%
Q3 25
27.6%
41.4%
Q2 25
31.9%
36.9%
Q1 25
30.2%
-3.7%
Q4 24
28.8%
25.6%
Q3 24
28.1%
25.0%
Q2 24
31.1%
16.5%
Q1 24
25.5%
29.1%
Operating Margin
NL
NL
PACB
PACB
Q4 25
7.6%
-92.3%
Q3 25
4.6%
-101.1%
Q2 25
6.9%
-112.8%
Q1 25
7.8%
-1154.5%
Q4 24
87.7%
-390.1%
Q3 24
6.0%
-160.3%
Q2 24
2.2%
-488.3%
Q1 24
3.6%
-209.6%
Net Margin
NL
NL
PACB
PACB
Q4 25
-82.2%
-90.4%
Q3 25
-19.7%
-98.9%
Q2 25
0.9%
-105.4%
Q1 25
1.7%
-1146.8%
Q4 24
43.1%
6.0%
Q3 24
107.0%
-151.9%
Q2 24
21.8%
-481.3%
Q1 24
18.0%
-201.4%
EPS (diluted)
NL
NL
PACB
PACB
Q4 25
$-0.63
$-0.11
Q3 25
$-0.16
$-0.13
Q2 25
$0.01
$-0.14
Q1 25
$0.01
$-1.44
Q4 24
$0.34
$-0.44
Q3 24
$0.74
$-0.22
Q2 24
$0.16
$-0.64
Q1 24
$0.14
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NL
NL
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$110.6M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$358.8M
$5.3M
Total Assets
$464.2M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NL
NL
PACB
PACB
Q4 25
$110.6M
$279.5M
Q3 25
$101.9M
$298.7M
Q2 25
$111.5M
$314.7M
Q1 25
$110.0M
$343.1M
Q4 24
$163.2M
$389.9M
Q3 24
$146.0M
$471.1M
Q2 24
$179.4M
$509.8M
Q1 24
$167.9M
$561.9M
Stockholders' Equity
NL
NL
PACB
PACB
Q4 25
$358.8M
$5.3M
Q3 25
$375.4M
$36.1M
Q2 25
$397.6M
$61.5M
Q1 25
$397.6M
$91.6M
Q4 24
$396.9M
$506.6M
Q3 24
$386.0M
$453.1M
Q2 24
$373.1M
$492.7M
Q1 24
$368.1M
$649.0M
Total Assets
NL
NL
PACB
PACB
Q4 25
$464.2M
$784.1M
Q3 25
$500.2M
$803.2M
Q2 25
$523.7M
$825.5M
Q1 25
$520.0M
$860.8M
Q4 24
$578.3M
$1.3B
Q3 24
$585.6M
$1.5B
Q2 24
$580.0M
$1.5B
Q1 24
$568.8M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NL
NL
PACB
PACB
Operating Cash FlowLast quarter
$-4.2M
$-19.1M
Free Cash FlowOCF − Capex
$-4.7M
$-19.9M
FCF MarginFCF / Revenue
-12.6%
-44.6%
Capex IntensityCapex / Revenue
1.6%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.1M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NL
NL
PACB
PACB
Q4 25
$-4.2M
$-19.1M
Q3 25
$7.9M
$-18.7M
Q2 25
$7.3M
$-29.4M
Q1 25
$-47.5M
$-44.1M
Q4 24
$9.0M
$-30.6M
Q3 24
$-5.7M
$-45.5M
Q2 24
$15.5M
$-54.3M
Q1 24
$6.7M
$-75.7M
Free Cash Flow
NL
NL
PACB
PACB
Q4 25
$-4.7M
$-19.9M
Q3 25
$7.0M
$-18.8M
Q2 25
$5.9M
$-29.9M
Q1 25
$-48.3M
$-45.4M
Q4 24
$8.7M
$-32.3M
Q3 24
$-6.1M
$-46.3M
Q2 24
$15.1M
$-55.7M
Q1 24
$6.4M
$-79.6M
FCF Margin
NL
NL
PACB
PACB
Q4 25
-12.6%
-44.6%
Q3 25
17.4%
-48.9%
Q2 25
14.7%
-75.3%
Q1 25
-119.9%
-122.3%
Q4 24
22.8%
-82.3%
Q3 24
-18.3%
-115.7%
Q2 24
42.1%
-154.8%
Q1 24
17.0%
-205.0%
Capex Intensity
NL
NL
PACB
PACB
Q4 25
1.6%
1.9%
Q3 25
2.5%
0.2%
Q2 25
3.3%
1.4%
Q1 25
2.0%
3.7%
Q4 24
0.6%
4.1%
Q3 24
1.4%
2.0%
Q2 24
1.2%
4.1%
Q1 24
0.8%
10.0%
Cash Conversion
NL
NL
PACB
PACB
Q4 25
Q3 25
Q2 25
20.53×
Q1 25
-71.18×
Q4 24
0.54×
-12.93×
Q3 24
-0.16×
Q2 24
1.98×
Q1 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NL
NL

Security Products$29.5M78%
Marine Components$8.2M22%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons